Abstract
The world has advanced in technology, health care, financial instruments and management, and other aspects of human endeavors. This advancement has impacted positively and negatively on the human race. Human demands are insatiable; hence, they crave more and more feats. This has created a lot of unnecessary pressure on man: the quest to meet targets, to achieve set goals, and to measure up with peer groups and pals. These unimaginable pressures have impacted negatively on the human and sometimes animal race. Such pressures have led to anxiety, depression, and sometimes insomnia. These have become a great economic and social burden. The need to address these burdens has increased over the years. Affected subjects sort care from orthodox and traditional medical practitioners. Traditional medical practitioner uses herbs and other natural products/methods to manage these conditionsĀ (anxiety, depression and/or insomnia). Herbs used for the management of anxiety, depression, and insomnia have been reported to be rich in alkaloids and phenolic compounds. Alkaloids with these activities often contain quercetin, rutin, apigenin, luteolin, and kaempferol. Extensive research has led to some of the findings, and revealed that these alkaloids exhibit their actions by acting on GABA receptors, serotonin receptors, monoamine oxidase (MAO), and BDNF expression. These herbs also alter endocrine, immunological, and monoamine systems, such as NE, DA, MDA formation, IL-6, BDNF, and TNF- Ī± levels. These mechanisms of action support their claims. The herbal remedy is worth trying if orthodox medicines fail.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
German-Ponciano LJ, Rosas-SĆ”nchez GU, Rivadeneyra-DomĆnguez E, RodrĆguez-Landa JF. Advances in the preclinical study of some flavonoids as potential antidepressant agents. Scientifica. 2018;2963565:1ā14.
American Psychiatric Association. Diagnostic and statistical manual for mental disorders, 5a ed (DSM-5). Arlington: American Psychiatric Publishing; 2013.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
Taylor DJ, Lichstein KL, Durrence HH. Insomnia as a health risk factor. Behav Sleep Med. 2003;1(4):227ā47.
Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study. PLoS Med. 2013;10(11):e1001547.
Institute of Health Metrics and Evaluation. Global Health Data Exchange (GHDx). Htts://vizhubhealthdataorg/gbd-results/. Accessed 4 march 2023.
Evans-Lacko S, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Benjet C, Bruffaerts R, Chiu WT, Florescu S, de Girolamo G, Gureje O, Haro JM, He Y, Hu C, Karam EG, Kawakami N, Lee S, Lund C, Kovess-Masfety V, Levinson D, Navarro-Mateu F, Pennell BE, Sampson NA, Scott KM, Tachimori H, ten Have M, Viana MC, Williams DR, Wojtyniak BJ, Zarkov Z, Kessler RC, Chatterji S, Thornicroft G. Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys. Psychol Med. 2018;48(9):1560ā71.
Firth J, Marx W, Dash S, Carney R, Teasdale SB, Solmi M, Stubbs B, Schuch FB, Carvalho AF, Jacka F, et al. The effects of dietary improvement on symptoms of depression and anxiety: a meta-analysis of randomized controlled trials. Psychosom Med. 2019;81:265ā80.
Dwyer AV, Whitten DL, Hawrelak JA. Herbal medicines, other than St. John`s wort, in the treatment of depression. Sci Rev Altern Med. 2011;16(1):281ā4.
Tegegne MT, Mossie TB, Awoke AA, Assaye AM, Gebrie BT, Eshetu DA. Depression and anxiety disorder among epileptic people at Amanuel specialized mental hospital, Addis Ababa, Ethiopia. BMC Psychiatry. 2015;15(1):210.
Kessler D, Bennewith O, Lewis G, Sharp D. Detection of depression and anxiety in primary care: follow up study. BMJ. 2002;325(7371):1016ā7.
UnĆ¼tzer J, Klap R, Sturm R, Young AS, Marmon T, Shatkin J, Wells KB. Mental disorders and the use of alternative medicine: results from a national survey. Am J Psychiatry. 2000;157(11):1851ā7.
Knaudt PR, Connor KM, Weisler RH, Churchill LE, Davidson JR. Alternative therapy use by psychiatric outpatients. J Nerv Ment Dis. 1999;187(11):692ā5.
Khan RA, Riaz A. Behavioral effects of Citrus Limon in rats. Metab Brain Dis. 2015;30(2):589ā96. https://doi.org/10.1007/s11011-014-9616-2. Epub 2014 Sep 17.
Viana MDM, da Silva Neto GJ, de Lima AA, Leite AB, Souza IT, Santana AEG, Campesatto EA, Moreira MSA. Citrus limon (L.) Burm f. Essential oil has anxiolytic and sedative properties by modulating GABAA-receptors human and animal health. Braz Arch Biol Technol. 2020;63:1.
Mittal S, Gupta P, Nigam V. Evaluation of antidepressant-like effect of Clitoria ternatea Linn. Res J Pharm Technol. 2021;14:6437ā41.
Motti R, de Falco B. Traditional herbal remedies used for managing anxiety. Horticulturae. 2021;7:523.
Pannu A, Sharma PC, Thakur VK, Goyal RK. Emerging role of flavonoids as the treatment of depression. Biomol Ther. 2021;2021(11):1825.
Uncini Manganelli RE, Tomei PE. Ethnopharmacobotanical studies of the Tuscan archipelago. J Ethnopharmacol. 1999;65:181ā202.
Guarino C, De Simone L, Santoro S. Ethnobotanical study of the Sannio area, Campania. South.Italy. Ethnobot Res Appl. 2008;6:255ā317.
Tuttolomondo T, Licata M, Leto C, Bonsangue G, Letizia Gargano M, Venturella G, La Bella S. Popular uses of wild plant species for medicinal purposes in the Nebrodi Regional Park (north-eastern Sicily, Italy). J Ethnopharmacol. 2014;157:21ā37.
Pieroni A, Nebel S, Quave C, Munz H, Heinrich M. Ethnopharmacology of liakra: traditional weedy vegetables of the Arbereshe of the vulture area in southern Italy. J Ethnopharmacol. 2002;81:165ā85.
Licata M, Tuttolomondo T, Leto C, Virga G, Bonsangue G, Cammalleri I, Gennaro MC, La Bella S. A survey of wild plant species for food use in Sicily (Italy)āresults of a 3-year study in four regional parks. J Ethnobiol Ethnomed. 2016;12:12.
Abourashed EA, Koetter U, Brattstrom A. In vitro binding experiments with a valerian, hops and their fixed combination extract (Ze91019) to selected central nervous system receptors. Phytomedicine. 2004;11:633ā8.
Kim HK, Son KH, Chang HW, Kang SS, Kim HP. Amentoflavone, a plant biflavone: a new potential anti-inflammatory agent. Arch Pharm Res. 1998;21:406ā10.
Ishola I, Chatterjee M, Tota S, Tadigopulla N, Adeyemi OO, Palit G, Shukla R. Antidepressant and anxiolytic effects of amentoflavone isolated from Cnestis ferruginea in mice. Pharmacol Biochem Behav. 2012;103:322ā31.
Salehi B, Venditti A, Sharifi-Rad M, Kregiel D, Sharifi-Rad J, Durazzo A, Lucarini M, Santini A, Souto EB, Novellino E, et al. The therapeutic potential of Apigenin. Int J Mol Sci. 2019;20:1305.
Li R, Wang X, Qin T, Qu R, Ma S. Apigenin ameliorates chronic mild stress-induced depressive behavior by inhibiting interleukin-1Ī² production and NLRP3 inflammasome activation in the rat brain. Behav Brain Res. 2016;296:318ā25.
Weng L, Guo X, Li Y, Yang X, Han Y. Apigenin reverses depression-like behavior induced by chronic corticosterone treatment in mice. Eur J Pharm. 2016;774:50ā4.
Ishisaka M, Kakefuda K, Yamauchi M, Tsuruma K, Shimazawa M, Tsuruta A, Hara H. Luteolin shows an antidepressantlike effect via suppressing endoplasmic reticulum stress. Biol Pharm Bull. 2011;34(9):1481ā6.
Liu B, Xu C, Wu X, Liu F, Du Y, Sun J, Tao J, Dong J. Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation. Neuroscience. 2015;294:193ā205.
Wei K, Xu Y, Zhao Z, Wu X, Du Y, Sun J, Yi T, Dong J, Liu B. Icariin alters the expression of glucocorticoid receptor, FKBP5 and SGK1 in rat brains following exposure to chronic mild stress. Int J Mol Med. 2016;38:337ā44.
Gong MJ, Han B, Wang SM, Liang SW, Zou ZJ. Icariin reverses corticosterone-induced depression-like behavior, decrease in hippocampal brain-derived neurotrophic factor (BDNF) andmetabolic network disturbances revealed by NMR based metabonomics in rats. J Pharm Biomed Anal. 2016;123:63ā73.
Butterweck V, Hegger M, Winterhoff H. Flavonoids of St. Johnās wort reduce HPA axis function in the rat. Planta Med. 2004;70:1008ā11.
Park S, Sim Y, Han P, Lee J, Suh H. Antidepressantlike effect of kaempferol and quercitirin, isolated from Opuntia ficus-indica var. Saboten Exp Neurobiol. 2010;19:24ā30.
DomitroviāC R, Rashed K, CvijanoviāC O, Vladimir-KneževiāC S, Å koda M, ViÅ”niāC A. Myricitrin exhibits antioxidant, antiinflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice. Chem Biol Interact. 2015;230:21ā9.
Meyer E, Mori MA, Campos AC, Andreatini R, GuimarĆ£es FS, Milani H, de Oliveira RMW. Myricitrin induces antidepressant-like effects and facilitates adult neurogenesis in mice. Behav Brain Res. 2017;316:59ā65.
Terao J, Yamaguchi S, Shirai M, Miyoshi M, Moon JH, Oshima S, Inakuma T, Tsushida T, Kato Y. Protection by quercetin and quercetin 3-O-beta-D-glucuronide of peroxynitrite-induced antioxidant consumption in human plasma low-density lipoprotein. Free Radic Res. 2001;35:925ā31.
Rinwa P, Kumar A. Quercetin suppress microglial neuroinflammatory response and induce antidepressent-like effect in olfactory bulbectomized rats. Neuroscience. 2013;255:86ā98.
Holzmann I, Silva LM, CorrĆŖa da Silva JA, Steimbach VM, De Souza MM. Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways. Pharm Biochem Behav. 2015;136:55ā63.
Pauff JM, Hille R. Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin. J Nat Prod. 2009;72:725ā31.
Petacci F, Freitas SS, Brunetti IL, Khalil NM. Inhibition of peroxidase activity and scavenging of reactive oxygen species by astilbin isolated from Dimorphandra mollis (Fabaceae, Caesalpinioideae). Biol Res. 2010;43:63ā74.
Lv QQ, Wu WJ, Guo XL, Liu RL, Yang YP, Zhou DS, Zhang JX, Liu JY. Antidepressant activity of astilbin: involvement of monoaminergic neurotransmitters and BDNF signal pathway. Biol Pharm Bull. 2014;37:987ā95.
Ren Z, Yan P, Zhu L, Yang H, Zhao Y, Kirby BP, Waddington JL, Zhen X. Dihydromyricetin exerts a rapid antidepressantlike effect in association with enhancement of BDNF expression and inhibition of neuroinflammation. Psychopharmacology. 2018;235:233ā44.
Liua L, Liu C, Wang Y, Wang P, Li Y, Li B. Herbal medicine for anxiety, depression and insomnia. Curr Neuropharmacol. 2015;13:481ā93.
Khanum F, Razack S. Anxiety-herbal treatment: a review. Res Rev Biomed Biotechnol. 2010;1(2):71ā89.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Otimenyin, S.O. (2023). Herbal Medicine for the Management of Anxiety, Depression, and Insomnia. In: Dhara, A.K., Mandal, S.C. (eds) Role of Herbal Medicines . Springer, Singapore. https://doi.org/10.1007/978-981-99-7703-1_13
Download citation
DOI: https://doi.org/10.1007/978-981-99-7703-1_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-7702-4
Online ISBN: 978-981-99-7703-1
eBook Packages: MedicineMedicine (R0)